简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2019-06-13 19:06 Terns Pharmaceuticals Initiates a Phase 1 Clinical Trial of TERN-101
2019-06-12 09:48 Boehringer Ingelheim and University of Dundee Highlight Successful PROTAC Drug Discovery Program and Extend Their Ongoing Anti-Cancer Alliance
2019-06-11 18:15 New Analysis Shows Sleep Apnea More Common in Americas than Previously Thought
2019-06-11 16:18 Microsure’s MUSA Microsurgery Robot Receives CE-mark
2019-06-11 15:59 Bioventus to Co-Develop Next Generation Placental Tissue Product for Knee Osteoarthritis with MTF Biologics
2019-06-11 10:01 Full data from CAROLINA® outcome trial support long-term cardiovascular safety profile of Trajenta®
2019-06-11 09:35 New post-hoc analysis shows consistent cardiorenal risk reductions of empagliflozin in a sub-group of adults with type 2 diabetes and chronic kidney disease without overt proteinuria
2019-06-10 14:53 Takeda Provides Update on TOURMALINE-AL1 Phase 3 Trial in AL Amyloidosis
2019-06-10 10:43 US FDA and EMA Accept Applications for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis
2019-06-06 17:54 Gavi, NEC, and Simprints to Deploy World’s First Scalable Child Fingerprint Identification Solution to Boost Immunization in Developing Countries
2019-06-06 17:51 Joe Kiani Named Honorary Academic by Mexican Academy of Surgery
2019-06-06 17:48 Otsuka Chemical Succeeded Part of the Cefixime Business from Astellas Pharma
2019-06-06 14:00 Yokogawa Takes Strategic Stake in Finnish Company Sensire Ltd. to Pursue Collaboration in Cold Chain Monitoring
2019-06-06 10:06 Takeda Presents Results from Lung Portfolio Including Phase 1/2 Study of TAK-788 in a Rare Form of NSCLC and New Data on Overall Health-Related Quality of Life for ALUNBRIG® (brigatinib)
2019-06-05 15:45 Ping An’s Healthtech Arm Cooperates with the Medical AI Lab Program of HKU
2019-06-04 19:46 Takeda Makes First Private Sector Pledge for Global Fund Replenishment
2019-06-04 09:57 New Ad-hoc Analysis of Phase 3 HELP Study™ Evaluates Prevention of HAE Attacks with TAKHZYRO® (lanadelumab) During Early Treatment Phase
2019-06-03 10:42 CureApp Announces Results from World’s First Randomized Control Study for Digital Therapeutic Smoking Cessation App
2019-05-31 20:17 WaveOptics and PEGATRON Demonstrate AiR Glasses Prototype at Both AWE and PEGATRON Day
2019-05-30 09:43 Qilu Pharmaceutical Expanding Biopharmaceutical Production Capacity with ABEC Bioreactor Systems

Business Wire Weibo

Press Releases

Latest Releases